Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antifungal medication
|
| gptkbp:approvedBy |
1981
|
| gptkbp:ATCCode |
gptkb:J02AC01
|
| gptkbp:CASNumber |
gptkb:86386-73-4
|
| gptkbp:chemicalFormula |
C13H12F2N6O
|
| gptkbp:contraindication |
hypersensitivity to fluconazole
|
| gptkbp:discoveredBy |
gptkb:Pfizer
|
| gptkbp:eliminationHalfLife |
20-50 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:genericName |
gptkb:fluconazole
|
| https://www.w3.org/2000/01/rdf-schema#label |
Diflucan
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:metabolism |
minimal hepatic
|
| gptkbp:pregnancyCategory |
D (in some indications)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
diarrhea abdominal pain headache rash |
| gptkbp:usedFor |
prevention of fungal infections in immunocompromised patients
treatment of cryptococcal meningitis treatment of fungal infections treatment of yeast infections |
| gptkbp:bfsParent |
gptkb:fluconazole
|
| gptkbp:bfsLayer |
6
|